Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Capio Biosciences logo — company profile

Capio Biosciences

Founded 2015 United States Madison, United States 4 employees Series A Total: $2.90M Biotechnology, Health Care

General Information

Company Name Capio Biosciences
Founded Year 2015
Location United States Madison, United States +1
Founders / Decision Makers
Team member
Employees 4
Industries Biotechnology, Health Care
Funding Stage Series A
Social

Get notified when Capio Biosciences moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Capio Biosciences

Capio Biosciences is a US-based biotech startup founded in 2015 by Seungpyo Hong PhD and Andrew Wang MD. The company's vision is to become the world's leading liquid biopsy company, providing valuable clinical information to improve patient outcomes. Capio Biosciences is committed to delivering high-value oncology diagnostics through its advanced platform called CapioCyte™, designed for the capture of circulating tumor cells (CTCs) from whole blood. CapioCyte™ utilizes biomimetic cell rolling and dendrimer-mediated multivalent cell capture, providing significantly greater capture sensitivity than other available platforms. It also offers enriched CTCs for post-capture molecular analysis such as FISH, RNA-Seq, and NGS. This innovative technology aligns with the current needs of cancer research and holds potential for clinical patient management in the future. With its pioneering approach, Capio Biosciences is positioned to make a significant impact in the field of oncology diagnostics. As the company continues to advance its platform and contribute to improving patient care decisions and outcomes, it presents an attractive opportunity for venture capital investment.

Taxonomy: liquid biopsy, oncology diagnostics, circulating tumor cells, biomimetic cell rolling, dendrimer-mediated capture, CTC capture sensitivity, molecular analysis, FISH, RNA-Seq, NGS, biotech startup, clinical patient management, cancer research, precision medicine, biomarker discovery

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 1 •••• •••• 05 Jan 2017

Capio Biosciences Alternatives & Competitors

Capio Biosciences vs
Vortex Biosciences
Vortex Biosciences United States

Circulating Tumor Cells (CTCs) are cancer cells, which have detached from the primary tumor and have...

Series Unknown
7 employees
Biotechnology, Health Care
Capio Biosciences vs
Onco Filtration, Inc.
Onco Filtration, Inc. United States

Onco Filtration has developed a fully patented, proprietary technology to fundamentally revolutioniz...

6 employees
Capio Biosciences vs
TellBio, Inc.
TellBio, Inc. United States

Freeing patients from the tyranny of cancer™

Series A
5 employees
Biotechnology, Health Care
Compare Capio Biosciences vs TellBio, Inc.

FAQ About Capio Biosciences

Our Vision: To be the world’s leading liquid biopsy company providing valuable clinical information to improve patient outcomes. Founded in 2015 by cofounders Seungpyo Hong PhD (UW, Madison WI) and Andrew Wang MD (UNC, Chapel Hill NC), Capio Biosciences is a biotech start-up focused on delivering h...
Capio Biosciences was founded in 2015.
Capio Biosciences is headquartered in Madison, United States.
Capio Biosciences operates in the following industries: Biotechnology, Health Care.
Capio Biosciences has approximately 4 employees.
Capio Biosciences has completed 1 funding round, raising a total of $2.90M. The latest funding stage is Series A.
Top alternatives and competitors to Capio Biosciences include Vortex Biosciences, Onco Filtration, Inc., TellBio, Inc., March Biosciences, xcellbio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Capio Biosciences and Vortex Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Capio Biosciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy